Medicare Enrolled
Dr. Amy Awaida, M.D.
Hematology & Oncology · Youngstown, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Awaida from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Awaida?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Awaida
Dr. Amy Awaida is a hematology & oncology specialist in Youngstown, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Awaida performed 56,707 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Awaida received a total of $11,874 from 92 pharmaceutical and/or device companies across 646 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Awaida is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in OH
$11,874 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗56,707
Medicare services
Top 9% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
15,160 | $2 | $20 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,260 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 9,880 | $1 | $8 |
| Denosumab injection (Prolia/Xgeva) | 7,860 | $18 | $55 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,366 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,580 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 950 | $1 | $114 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
711 | $21 | $157 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $85 | $231 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
437 | $90 | $707 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
404 | $55 | $152 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
325 | $10 | $96 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
324 | $11 | $108 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
238 | $129 | $310 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
208 | $14 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
207 | $44 | $313 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
184 | $46 | $344 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
155 | $2 | $19 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
152 | $1 | $7 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
151 | $0 | $10 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
92 | $24 | $145 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
91 | $19 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
90 | $88 | $239 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
70 | $9 | $75 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
66 | $39 | $289 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
63 | $16 | $114 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 60 | $344 | $1,722 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
46 | $23 | $256 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
36 | $62 | $259 |
| New patient office visit, complex (60-74 min) | 30 | $150 | $445 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $101 | $353 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $97 | $306 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
26.8% high complexity
70.4% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,874
Total received (2018-2024)
Avg $1,696/year across 7 years
Top 26% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
646
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,157
2023
$2,898
2022
$1,030
2021
$196
2020
$522
2019
$2,036
2018
$2,034
Payments by company (2024)
Celgene Corporation
$545
Novartis Pharmaceuticals Corporation
$298
Takeda Pharmaceuticals U.S.A., Inc.
$217
Merck Sharp & Dohme LLC
$199
ABBVIE INC.
$179
PFIZER INC.
$176
Astellas Pharma US Inc
$145
GENZYME CORPORATION
$131
AstraZeneca Pharmaceuticals LP
$84
E.R. Squibb & Sons, L.L.C.
$82
Genentech USA, Inc.
$80
Daiichi Sankyo Inc.
$77
Regeneron Healthcare Solutions, Inc.
$75
Eisai Inc.
$66
Janssen Biotech, Inc.
$62
Aveo Pharmaceuticals, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$59
Pharmacosmos Therapeutics Inc.
$56
Blueprint Medicines Corporation
$48
Acrotech Biopharma Inc.
$47
Mirati Therapeutics, Inc.
$46
RECORDATI_RARE_DISEASES_INC.
$43
Exelixis Inc.
$38
Gilead Sciences, Inc.
$37
Incyte Corporation
$35
GlaxoSmithKline, LLC.
$34
Bayer Healthcare Pharmaceuticals Inc.
$30
Lilly USA, LLC
$28
TAIHO ONCOLOGY, INC.
$28
Kyowa Kirin, Inc.
$23
Tempus AI, Inc
$23
Deciphera Pharmaceuticals Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
SOBI, INC
$18
Apellis Pharmaceuticals, Inc.
$18
Alexion Pharmaceuticals, Inc.
$16
Karyopharm Therapeutics Inc.
$16
Top 3 companies account for 33.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,261
E.R. Squibb & Sons, L.L.C.
$838
Celgene Corporation
$828
Takeda Pharmaceuticals U.S.A., Inc.
$705
PFIZER INC.
$686
Amgen Inc.
$498
AstraZeneca Pharmaceuticals LP
$460
Merck Sharp & Dohme LLC
$443
Genentech USA, Inc.
$375
Astellas Pharma US Inc
$348
Janssen Biotech, Inc.
$318
Lilly USA, LLC
$312
GENZYME CORPORATION
$310
Exelixis Inc.
$263
Merck Sharp & Dohme Corporation
$221
Daiichi Sankyo Inc.
$196
ASD SPECIALTY HEALTHCARE, LLC
$192
Pharmacyclics LLC, An AbbVie Company
$183
ABBVIE INC.
$179
Bayer HealthCare Pharmaceuticals Inc.
$160
Eisai Inc.
$156
Regeneron Healthcare Solutions, Inc.
$141
EMD Serono, Inc.
$138
Seagen Inc.
$125
Ipsen Biopharmaceuticals, Inc
$108
Genmab U.S., Inc.
$99
Acrotech Biopharma Inc.
$90
Epizyme, Inc.,
$88
EISAI INC.
$79
Pharmacosmos Therapeutics Inc.
$77
GlaxoSmithKline, LLC.
$75
TESARO, Inc.
$74
Alexion Pharmaceuticals, Inc.
$72
Karyopharm Therapeutics Inc.
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
JAZZ PHARMACEUTICALS INC.
$70
ASD Specialty Healthcare, LLC
$70
Blueprint Medicines Corporation
$66
Incyte Corporation
$63
Aveo Pharmaceuticals, Inc.
$60
Kyowa Kirin, Inc.
$53
Gilead Sciences, Inc.
$49
Myovant Sciences Inc.
$48
Mirati Therapeutics, Inc.
$46
G1 Therapeutics, Inc.
$44
Deciphera Pharmaceuticals Inc.
$43
RECORDATI_RARE_DISEASES_INC.
$43
Heron Therapeutics, Inc.
$37
Mylan Institutional Inc.
$36
AVEO Pharmaceuticals, Inc.
$35
Sun Pharmaceutical Industries Inc.
$35
MEDIVATION FIELD SOLUTIONS LLC
$32
Taiho Oncology, Inc.
$31
Boston Scientific Corporation
$30
Bayer Healthcare Pharmaceuticals Inc.
$30
TAIHO ONCOLOGY, INC.
$28
Pharmacyclics LLC, an AbbVie Company
$28
AbbVie, Inc.
$27
Janssen Pharmaceuticals, Inc
$27
BeiGene USA, Inc.
$26
Lexicon Pharmaceuticals, Inc.
$26
Puma Biotechnology, Inc.
$26
ARRAY BIOPHARMA INC
$24
AbbVie Inc.
$23
Tempus AI, Inc
$23
Helsinn Therapeutics (U.S.), Inc.
$22
MorphoSys, US Inc.
$22
CTI BioPharma Corp.
$22
Myriad Genetic Laboratories, Inc.
$22
Global Blood Therapeutics, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
Emmaus Medical, Inc.
$19
SOBI, INC
$18
Adaptive Biotechnologies Corporation
$18
Apellis Pharmaceuticals, Inc.
$18
Dendreon Pharmaceuticals LLC
$17
INSYS Therapeutics Inc
$17
ImmunoGen, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
Tolmar, Inc.
$17
Tactile Systems Technology Inc
$17
Stemline Therapeutics Inc.
$16
Secura Bio, Inc.
$16
ADC Therapeutics America, Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Kite Pharma, Inc.
$14
Acrotech Biopharma LLC
$14
Clovis Oncology, Inc.
$14
AMAG Pharmaceuticals, Inc.
$13
Seattle Genetics, Inc.
$12
Purdue Pharma L.P.
$12
Shionogi Inc
$11
Top 3 companies account for 24.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALTUVIIIO · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FRUZAQLA · FULPHILA · Fabhalta · Farydak · Flexitouch Plus · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · Inrebic · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Mulpleta · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezum Generator · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYMPROIC · SYNDROS · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · WATCHMAN Access System · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
22
County median income
$55,576
Nearest hospital to ZIP centroid (approximate)
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Awaida is a mixed practice specialist, with above-average Medicare volume (top 9% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Awaida experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Awaida performed 15,160 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Awaida receive payments from pharmaceutical companies?
Yes. Dr. Awaida received a total of $11,874 from 92 companies across 646 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Awaida's costs compare to other hematology & oncology specialists in Youngstown?
Dr. Awaida's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Awaida) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Youngstown
Browse hematology & oncology specialists in Youngstown ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology